EI
TXMD icon

Ellevest Inc’s TherapeuticsMD TXMD Stock Holding History

Ellevest Inc’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-8
Closed – – 1656
2021
Q3 		$0 Buy
+8
New +$355 ﹤0.01% 1583

Other funds holding TXMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ellevest Inc's TXMD Position: Q4 2021 in Review

Ellevest Inc sold out of TherapeuticsMD (TXMD) in Q4 2021, closing a stake of 8 shares.

Ellevest Inc first reported a position in TXMD in Q3 2021 and held it in 1 quarter. The position peaked at $0 in Q3 2021. 131 funds tracked by Wall St. Rank hold TXMD as of Q4 2021.

  • Ellevest Inc reported no remaining TherapeuticsMD position as of Q4 2021 after selling out during the quarter.
  • Ellevest Inc sold 8 TherapeuticsMD shares in Q4 2021.
  • Ellevest Inc first reported a position in TherapeuticsMD in Q3 2021 and held it in 1 quarter.
  • Ellevest Inc's TherapeuticsMD position peaked at $0 in Q3 2021.
  • 131 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2021.

Based on Ellevest Inc's 13F filing for Q4 2021, filed 24 Jan 2022.